secwatch.observer — SEC 8-K summary
======================================

Issuer:     CHINA PHARMA HOLDINGS, INC. (CPHI)
CIK:        0001106644
Form:       8-K
Filed at:   2022-06-22T23:59:59+00:00
Accession:  0001213900-22-034328
Event type: regulatory
Sentiment:  negative
Materiality: 0.70
Item codes: 3.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

CPHI receives NYSE American delisting notice for insufficient stockholders' equity
--------------------------------------------------------------------------------

- Stockholders' equity was $5.3M as of March 31, 2022, below the $6.0M minimum required under Section 1003(a)(iii).
- Company must submit a compliance plan by July 15, 2022 to regain compliance by December 15, 2023.
- CPHI stock will continue trading on NYSE American under symbol CPHI with added '.BC' designation.
- Failure to submit or comply with the plan may result in commencement of delisting proceedings.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1106644/000121390022034328/0001213900-22-034328-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1106644/000121390022034328/ea161911-8k_chinapharma.htm
  HTML page:      https://secwatch.observer/filing/0001213900-22-034328

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer